Iradimed (IRMD) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.64% |
| Dec 31, 2025 | 4.08% |
| Sep 30, 2025 | -0.56% |
| Jun 30, 2025 | -0.53% |
| Mar 31, 2025 | 0.40% |
| Dec 31, 2024 | 5.81% |
| Sep 30, 2024 | 4.46% |
| Jun 30, 2024 | 4.72% |
| Mar 31, 2024 | 5.04% |
| Dec 31, 2023 | 1.44% |
| Sep 30, 2023 | 2.13% |
| Jun 30, 2023 | 1.39% |
| Mar 31, 2023 | 3.38% |
| Dec 31, 2022 | -7.81% |
| Sep 30, 2022 | -9.31% |
| Jun 30, 2022 | -11.32% |
| Mar 31, 2022 | -12.87% |
| Dec 31, 2021 | -22.05% |
| Sep 30, 2021 | -23.90% |
| Jun 30, 2021 | -23.90% |
| Mar 31, 2021 | -23.59% |
| Dec 31, 2020 | -25.43% |
| Sep 30, 2020 | -25.53% |
| Jun 30, 2020 | -26.11% |
| Mar 31, 2020 | -23.38% |
| Dec 31, 2019 | -21.67% |
| Sep 30, 2019 | -21.36% |
| Jun 30, 2019 | -23.34% |
| Mar 31, 2019 | -14.58% |
| Dec 31, 2018 | -8.43% |
| Sep 30, 2018 | -10.02% |
| Jun 30, 2018 | -13.21% |
| Mar 31, 2018 | -14.29% |
| Dec 31, 2017 | -14.89% |
| Sep 30, 2017 | -11.65% |
| Jun 30, 2017 | -74.09% |
| Mar 31, 2017 | -105.51% |
| Dec 31, 2016 | -111.67% |
| Sep 30, 2016 | -126.74% |
| Jun 30, 2016 | -110.42% |